Generate Biomedicines Stock
HealthTechLooking to sell Generate Biomedicines stock or options?
Generate Biomedicines is the developer of a generative biology platform that is designed to create new drugs across protein modalities and protein therapeutics. The company's platform utilizes machine learning to comprehend the genetic code that determines protein functions, leading to the generation of antibodies, peptides, enzymes, as well as cell and gene therapies to cater to various therapeutic requirements. This allows researchers to introduce groundbreaking medicines to patients.
Alumni Ventures, ARCH Venture Partners, Pictet Alternative Advisors, T. Rowe Price Group, Nvidia, Flagship Pioneering, Partners Investment, Novartis Institutes for BioMedical Research, Abu Dhabi Investment Authority, Fidelity Management & Research, Amgen, Alaska Permanent Fund, Modi Ventures, Altitude Life Science Ventures, NVentures (Santa Clara), Morningside Group, March Capital, Maps Capital, Mirae Asset Capital.